Soluventis GmbH

Soluventis GmbH develops a nanocarrier-based drug delivery method that transports active pharmaceutical substances into cells, aiming to avoid premature elimination by the liver and kidneys and to be excreted without side effects. The technology is intended for pharmaceutical applications to enable targeted intracellular delivery of therapeutics.